| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate |
2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b60c034f619308ac7841952b584c8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d022ae59666c402d06c173eacfb7b5a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39aadf3546aef18b1dbc184884cc2cd0 |
| publicationDate |
2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2018005894-A |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, DERIVED FROM 7-AZAINDOLIN-2-ONA OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME. |
| abstract |
The present invention relates to a 7-azaindolin-2-one derivative or a pharmaceutically acceptable salt thereof, and the 7-azaindolin-2-one derivative or the pharmaceutically acceptable salt thereof can be favorably used as a medicinal material. to inhibit cancer growth and cancer metastasis. |
| priorityDate |
2015-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |